Politics of Intellectual Property Rights (IPRs) in Medicine: The Dichotomies

Rajiv Ranjan

FIIB Business Review, 2018, vol. 7, issue 2, 69-79

Abstract: From a public policy perspective, how publicly funded medical research gets privatized by the award of patents is a critical issue. It leads to a loss of welfare for the poor people throughout the world and more so in the developing world. This raises issues related to health care provisioning and financing—namely public versus private intervention debate—accessibility and affordability issues, lack of medical researcher’s attention to the diseases pertaining to the poor only, geopolitical issues between the developed world and the developing world with regards to TRIPS among a host of other issues. In this article, it is shown how power and politics operate along dimensions of poor–rich, developed–developing world, public–private–NGOs and international agencies to keep the idea of IPRs as a critical instrument for health innovation alive.

Keywords: IPRs; power and politics; rich–poor; public–private; developed–developing (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/2319714518789762 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:fbbsrw:v:7:y:2018:i:2:p:69-79

DOI: 10.1177/2319714518789762

Access Statistics for this article

More articles in FIIB Business Review
Bibliographic data for series maintained by SAGE Publications ().